APO Research
Talk to an analyst

APO RESEARCH · REPORT

NK Cell Serum-Free Medium

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global NK Cell Serum-Free Medium Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

8 January 2026194 pages

Choose your research edition.

Industry ResearchNK Cell Serum-Free Medium Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal NK Cell Serum-Free Medium Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal NK Cell Serum-Free Medium Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal NK Cell Serum-Free Medium Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal NK Cell Serum-Free Medium Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global NK Cell Serum-Free Medium market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for NK Cell Serum-Free Medium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for NK Cell Serum-Free Medium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for NK Cell Serum-Free Medium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for NK Cell Serum-Free Medium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of NK Cell Serum-Free Medium include Fujifilm, Thermo Fisher Scientific, BioLife Solutions, Sartorius, Cytiva, WAK-Chemie Medical, Zenoaq, Merck and Vitrolife Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global NK Cell Serum-Free Medium market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of NK Cell Serum-Free Medium and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents NK Cell Serum-Free Medium sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the NK Cell Serum-Free Medium market size, projected growth trends, production technologies, key applications, and end-use industries.

NK Cell Serum-Free Medium Segment by Company

Fujifilm

Thermo Fisher Scientific

BioLife Solutions

Sartorius

Cytiva

WAK-Chemie Medical

Zenoaq

Merck

Vitrolife Group

Lifeline (ISCO)

Capricorn

BioLegend

Miltenyi Biotec

CooperSurgical

Yocon Biology

Selcell

Shanghai Epizyme

ExCell Bio

NK Cell Serum-Free Medium Segment by Type

Basic Level

Research Level

NK Cell Serum-Free Medium Segment by Application

Biotechnology Company

Universities and Research Institutes

Hospital

NK Cell Serum-Free Medium Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NK Cell Serum-Free Medium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of NK Cell Serum-Free Medium and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NK Cell Serum-Free Medium.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the NK Cell Serum-Free Medium market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of NK Cell Serum-Free Medium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of NK Cell Serum-Free Medium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of NK Cell Serum-Free Medium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. NK Cell Serum-Free Medium Industry Trends Table 2. NK Cell Serum-Free Medium Industry Drivers Table 3. NK Cell Serum-Free Medium Industry Opportunities and Challenges Table 4. NK Cell Serum-Free Medium Industry Restraints Table 5. Global NK Cell Serum-Free Medium Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global NK Cell Serum-Free Medium Revenue Market Share by Manufacturers (2021-2026) Table 7. Global NK Cell Serum-Free Medium Sales by Manufacturers (L) & (2021-2026) Table 8. Global NK Cell Serum-Free Medium Sales Market Share by Manufacturers Table 9. Global NK Cell Serum-Free Medium Average Sales Price (USD/L) of Manufacturers (2021-2026) Table 10. Global NK Cell Serum-Free Medium Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global NK Cell Serum-Free Medium Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global NK Cell Serum-Free Medium Manufacturers, Product Type & Application Table 13. Global NK Cell Serum-Free Medium Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global NK Cell Serum-Free Medium by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Basic Level Table 17. Major Manufacturers of Research Level Table 18. Global NK Cell Serum-Free Medium Sales by Type 2021 VS 2025 VS 2032 (L) Table 19. Global NK Cell Serum-Free Medium Sales by Type (2021-2026) & (L) Table 20. Global NK Cell Serum-Free Medium Sales by Type (2027-2032) & (L) Table 21. Global NK Cell Serum-Free Medium Sales Market Share by Type (2021-2026) Table 22. Global NK Cell Serum-Free Medium Sales Market Share by Type (2027-2032) Table 23. Global NK Cell Serum-Free Medium Revenue by Type 2021 VS 2025 VS 2032 (L) Table 24. Global NK Cell Serum-Free Medium Revenue by Type (2021-2026) & (L) Table 25. Global NK Cell Serum-Free Medium Revenue by Type (2027-2032) & (L) Table 26. Global NK Cell Serum-Free Medium Revenue Market Share by Type (2021-2026) Table 27. Global NK Cell Serum-Free Medium Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Biotechnology Company Table 29. Major Manufacturers of Universities and Research Institutes Table 30. Major Manufacturers of Hospital Table 31. Global NK Cell Serum-Free Medium Sales by Application 2021 VS 2025 VS 2032 (L) Table 32. Global NK Cell Serum-Free Medium Sales by Application (2021-2026) & (L) Table 33. Global NK Cell Serum-Free Medium Sales by Application (2027-2032) & (L) Table 34. Global NK Cell Serum-Free Medium Sales Market Share by Application (2021-2026) Table 35. Global NK Cell Serum-Free Medium Sales Market Share by Application (2027-2032) Table 36. Global NK Cell Serum-Free Medium Revenue by Application 2021 VS 2025 VS 2032 (L) Table 37. Global NK Cell Serum-Free Medium Revenue by Application (2021-2026) & (L) Table 38. Global NK Cell Serum-Free Medium Revenue by Application (2027-2032) & (L) Table 39. Global NK Cell Serum-Free Medium Revenue Market Share by Application (2021-2026) Table 40. Global NK Cell Serum-Free Medium Revenue Market Share by Application (2027-2032) Table 41. Global NK Cell Serum-Free Medium Sales by Region: 2021 VS 2025 VS 2032 (L) Table 42. Global NK Cell Serum-Free Medium Sales by Region (2021-2026) & (L) Table 43. Global NK Cell Serum-Free Medium Sales Market Share by Region (2021-2026) Table 44. Global NK Cell Serum-Free Medium Sales Forecasted by Region (2027-2032) & (L) Table 45. Global NK Cell Serum-Free Medium Sales Forecasted Market Share by Region (2027-2032) Table 46. North America NK Cell Serum-Free Medium Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 47. North America NK Cell Serum-Free Medium Sales by Country (2021-2026) & (L) Table 48. North America NK Cell Serum-Free Medium Sales by Country (2027-2032) & (L) Table 49. Europe NK Cell Serum-Free Medium Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 50. Europe NK Cell Serum-Free Medium Sales by Country (2021-2026) & (L) Table 51. Europe NK Cell Serum-Free Medium Sales by Country (2027-2032) & (L) Table 52. Asia Pacific NK Cell Serum-Free Medium Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 53. Asia Pacific NK Cell Serum-Free Medium Sales by Country (2021-2026) & (L) Table 54. Asia Pacific NK Cell Serum-Free Medium Sales by Country (2027-2032) & (L) Table 55. South America, Middle East and Africa NK Cell Serum-Free Medium Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 56. South America, Middle East and Africa NK Cell Serum-Free Medium Sales by Country (2021-2026) & (L) Table 57. South America, Middle East and Africa NK Cell Serum-Free Medium Sales by Country (2027-2032) & (L) Table 58. Global NK Cell Serum-Free Medium Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global NK Cell Serum-Free Medium Revenue by Region (2021-2026) & (US$ Million) Table 60. Global NK Cell Serum-Free Medium Revenue by Region (2027-2032) & (US$ Million) Table 61. Global NK Cell Serum-Free Medium Revenue Market Share by Region (2021-2026) Table 62. Global NK Cell Serum-Free Medium Revenue Market Share by Region (2027-2032) Table 63. Fujifilm Company Information Table 64. Fujifilm Business Overview Table 65. Fujifilm NK Cell Serum-Free Medium Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Fujifilm NK Cell Serum-Free Medium Product Portfolio Table 67. Fujifilm Recent Development Table 68. Thermo Fisher Scientific Company Information Table 69. Thermo Fisher Scientific Business Overview Table 70. Thermo Fisher Scientific NK Cell Serum-Free Medium Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Thermo Fisher Scientific NK Cell Serum-Free Medium Product Portfolio Table 72. Thermo Fisher Scientific Recent Development Table 73. BioLife Solutions Company Information Table 74. BioLife Solutions Business Overview Table 75. BioLife Solutions NK Cell Serum-Free Medium Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. BioLife Solutions NK Cell Serum-Free Medium Product Portfolio Table 77. BioLife Solutions Recent Development Table 78. Sartorius Company Information Table 79. Sartorius Business Overview Table 80. Sartorius NK Cell Serum-Free Medium Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Sartorius NK Cell Serum-Free Medium Product Portfolio Table 82. Sartorius Recent Development Table 83. Cytiva Company Information Table 84. Cytiva Business Overview Table 85. Cytiva NK Cell Serum-Free Medium Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Cytiva NK Cell Serum-Free Medium Product Portfolio Table 87. Cytiva Recent Development Table 88. WAK-Chemie Medical Company Information Table 89. WAK-Chemie Medical Business Overview Table 90. WAK-Chemie Medical NK Cell Serum-Free Medium Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. WAK-Chemie Medical NK Cell Serum-Free Medium Product Portfolio Table 92. WAK-Chemie Medical Recent Development Table 93. Zenoaq Company Information Table 94. Zenoaq Business Overview Table 95. Zenoaq NK Cell Serum-Free Medium Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Zenoaq NK Cell Serum-Free Medium Product Portfolio Table 97. Zenoaq Recent Development Table 98. Merck Company Information Table 99. Merck Business Overview Table 100. Merck NK Cell Serum-Free Medium Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Merck NK Cell Serum-Free Medium Product Portfolio Table 102. Merck Recent Development Table 103. Vitrolife Group Company Information Table 104. Vitrolife Group Business Overview Table 105. Vitrolife Group NK Cell Serum-Free Medium Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Vitrolife Group NK Cell Serum-Free Medium Product Portfolio Table 107. Vitrolife Group Recent Development Table 108. Lifeline (ISCO) Company Information Table 109. Lifeline (ISCO) Business Overview Table 110. Lifeline (ISCO) NK Cell Serum-Free Medium Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Lifeline (ISCO) NK Cell Serum-Free Medium Product Portfolio Table 112. Lifeline (ISCO) Recent Development Table 113. Capricorn Company Information Table 114. Capricorn Business Overview Table 115. Capricorn NK Cell Serum-Free Medium Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Capricorn NK Cell Serum-Free Medium Product Portfolio Table 117. Capricorn Recent Development Table 118. BioLegend Company Information Table 119. BioLegend Business Overview Table 120. BioLegend NK Cell Serum-Free Medium Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. BioLegend NK Cell Serum-Free Medium Product Portfolio Table 122. BioLegend Recent Development Table 123. Miltenyi Biotec Company Information Table 124. Miltenyi Biotec Business Overview Table 125. Miltenyi Biotec NK Cell Serum-Free Medium Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Miltenyi Biotec NK Cell Serum-Free Medium Product Portfolio Table 127. Miltenyi Biotec Recent Development Table 128. CooperSurgical Company Information Table 129. CooperSurgical Business Overview Table 130. CooperSurgical NK Cell Serum-Free Medium Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. CooperSurgical NK Cell Serum-Free Medium Product Portfolio Table 132. CooperSurgical Recent Development Table 133. Yocon Biology Company Information Table 134. Yocon Biology Business Overview Table 135. Yocon Biology NK Cell Serum-Free Medium Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Yocon Biology NK Cell Serum-Free Medium Product Portfolio Table 137. Yocon Biology Recent Development Table 138. Selcell Company Information Table 139. Selcell Business Overview Table 140. Selcell NK Cell Serum-Free Medium Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Selcell NK Cell Serum-Free Medium Product Portfolio Table 142. Selcell Recent Development Table 143. Shanghai Epizyme Company Information Table 144. Shanghai Epizyme Business Overview Table 145. Shanghai Epizyme NK Cell Serum-Free Medium Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Shanghai Epizyme NK Cell Serum-Free Medium Product Portfolio Table 147. Shanghai Epizyme Recent Development Table 148. ExCell Bio Company Information Table 149. ExCell Bio Business Overview Table 150. ExCell Bio NK Cell Serum-Free Medium Sales (L), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. ExCell Bio NK Cell Serum-Free Medium Product Portfolio Table 152. ExCell Bio Recent Development Table 153. Key Raw Materials Table 154. Raw Materials Key Suppliers Table 155. NK Cell Serum-Free Medium Distributors List Table 156. NK Cell Serum-Free Medium Customers List Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. NK Cell Serum-Free Medium Product Image Figure 2. Global NK Cell Serum-Free Medium Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global NK Cell Serum-Free Medium Market Size (2021-2032) & (US$ Million) Figure 4. Global NK Cell Serum-Free Medium Sales (2021-2032) & (L) Figure 5. Global NK Cell Serum-Free Medium Average Price (USD/L) & (2021-2032) Figure 6. Global Top 5 and 10 NK Cell Serum-Free Medium Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Basic Level Image Figure 9. Research Level Image Figure 10. Global NK Cell Serum-Free Medium Sales by Type (2021 VS 2025 VS 2032) & (L) Figure 11. Global NK Cell Serum-Free Medium Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global NK Cell Serum-Free Medium Sales Market Share by Type (2021-2032) Figure 13. Global NK Cell Serum-Free Medium Revenue by Type (2021 VS 2025 VS 2032) & (L) Figure 14. Global NK Cell Serum-Free Medium Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global NK Cell Serum-Free Medium Revenue Market Share by Type (2021-2032) Figure 16. Biotechnology Company Image Figure 17. Universities and Research Institutes Image Figure 18. Hospital Image Figure 19. Global NK Cell Serum-Free Medium Sales by Application (2021 VS 2025 VS 2032) & (L) Figure 20. Global NK Cell Serum-Free Medium Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global NK Cell Serum-Free Medium Sales Market Share by Application (2021-2032) Figure 22. Global NK Cell Serum-Free Medium Revenue by Application (2021 VS 2025 VS 2032) & (L) Figure 23. Global NK Cell Serum-Free Medium Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global NK Cell Serum-Free Medium Revenue Market Share by Application (2021-2032) Figure 25. North America NK Cell Serum-Free Medium Sales and Growth Rate (2021-2032) & (L) Figure 26. North America NK Cell Serum-Free Medium Sales Market Share by Country (2021-2032) Figure 27. U.S. NK Cell Serum-Free Medium Sales and Growth Rate (2021-2032) & (L) Figure 28. Canada NK Cell Serum-Free Medium Sales and Growth Rate (2021-2032) & (L) Figure 29. Mexico NK Cell Serum-Free Medium Sales and Growth Rate (2021-2032) & (L) Figure 30. Europe NK Cell Serum-Free Medium Sales and Growth Rate (2021-2032) & (L) Figure 31. Europe NK Cell Serum-Free Medium Sales Market Share by Country (2021-2032) Figure 32. Germany NK Cell Serum-Free Medium Sales and Growth Rate (2021-2032) & (L) Figure 33. France NK Cell Serum-Free Medium Sales and Growth Rate (2021-2032) & (L) Figure 34. U.K. NK Cell Serum-Free Medium Sales and Growth Rate (2021-2032) & (L) Figure 35. Italy NK Cell Serum-Free Medium Sales and Growth Rate (2021-2032) & (L) Figure 36. Netherlands NK Cell Serum-Free Medium Sales and Growth Rate (2021-2032) & (L) Figure 37. Asia Pacific NK Cell Serum-Free Medium Sales and Growth Rate (2021-2032) & (L) Figure 38. Asia Pacific NK Cell Serum-Free Medium Sales Market Share by Country (2021-2032) Figure 39. China NK Cell Serum-Free Medium Sales and Growth Rate (2021-2032) & (L) Figure 40. Japan NK Cell Serum-Free Medium Sales and Growth Rate (2021-2032) & (L) Figure 41. South Korea NK Cell Serum-Free Medium Sales and Growth Rate (2021-2032) & (L) Figure 42. Southeast Asia NK Cell Serum-Free Medium Sales and Growth Rate (2021-2032) & (L) Figure 43. India NK Cell Serum-Free Medium Sales and Growth Rate (2021-2032) & (L) Figure 44. Australia NK Cell Serum-Free Medium Sales and Growth Rate (2021-2032) & (L) Figure 45. South America, Middle East and Africa NK Cell Serum-Free Medium Sales and Growth Rate (2021-2032) & (L) Figure 46. South America, Middle East and Africa NK Cell Serum-Free Medium Sales Market Share by Country (2021-2032) Figure 47. Brazil NK Cell Serum-Free Medium Sales and Growth Rate (2021-2032) & (L) Figure 48. South Africa NK Cell Serum-Free Medium Sales and Growth Rate (2021-2032) & (L) Figure 49. Saudi Arabia NK Cell Serum-Free Medium Sales and Growth Rate (2021-2032) & (L) Figure 50. Turkey NK Cell Serum-Free Medium Sales and Growth Rate (2021-2032) & (L) Figure 51. Argentina NK Cell Serum-Free Medium Sales and Growth Rate (2021-2032) & (L) Figure 52. UAE NK Cell Serum-Free Medium Sales and Growth Rate (2021-2032) & (L) Figure 53. Egypt NK Cell Serum-Free Medium Sales and Growth Rate (2021-2032) & (L) Figure 54. Chile NK Cell Serum-Free Medium Sales and Growth Rate (2021-2032) & (L) Figure 55. Global NK Cell Serum-Free Medium Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global NK Cell Serum-Free Medium Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America NK Cell Serum-Free Medium Revenue (2021-2032) & (US$ Million) Figure 58. North America NK Cell Serum-Free Medium Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe NK Cell Serum-Free Medium Revenue (2021-2032) & (US$ Million) Figure 60. Europe NK Cell Serum-Free Medium Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific NK Cell Serum-Free Medium Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific NK Cell Serum-Free Medium Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa NK Cell Serum-Free Medium Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa NK Cell Serum-Free Medium Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. NK Cell Serum-Free Medium Value Chain Figure 66. Manufacturing Cost Structure Figure 67. NK Cell Serum-Free Medium Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Basic Level
  • Research Level
Applications
  • Biotechnology Company
  • Universities and Research Institutes
  • Hospital
Companies covered
  • Fujifilm
  • Thermo Fisher Scientific
  • BioLife Solutions
  • Sartorius
  • Cytiva
  • WAK-Chemie Medical
  • Zenoaq
  • Merck
  • Vitrolife Group
  • Lifeline (ISCO)
  • Capricorn
  • BioLegend
  • Miltenyi Biotec
  • CooperSurgical
  • Yocon Biology
  • Selcell
  • Shanghai Epizyme
  • ExCell Bio

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global NK Cell Serum-Free Medium Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global NK Cell Serum-Free Medium Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global NK Cell Serum-Free Medium Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global NK Cell Serum-Free Medium Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global NK Cell Serum-Free Medium Market Dynamics
  1. 2.1 NK Cell Serum-Free Medium Industry Trends
  2. 2.2 NK Cell Serum-Free Medium Industry Drivers
  3. 2.3 NK Cell Serum-Free Medium Industry Opportunities and Challenges
  4. 2.4 NK Cell Serum-Free Medium Industry Restraints
3 NK Cell Serum-Free Medium Market by Manufacturers
  1. 3.1 Global NK Cell Serum-Free Medium Revenue by Manufacturers (2021-2026)
  2. 3.2 Global NK Cell Serum-Free Medium Sales by Manufacturers (2021-2026)
  3. 3.3 Global NK Cell Serum-Free Medium Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global NK Cell Serum-Free Medium Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global NK Cell Serum-Free Medium Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global NK Cell Serum-Free Medium Manufacturers, Product Type & Application
  7. 3.7 Global NK Cell Serum-Free Medium Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global NK Cell Serum-Free Medium Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 NK Cell Serum-Free Medium Players Market Share by Revenue in 2025
  11. 3.8.3 2025 NK Cell Serum-Free Medium Tier 1, Tier 2, and Tier 3
4 NK Cell Serum-Free Medium Market by Type
  1. 4.1 NK Cell Serum-Free Medium Type Introduction
  2. 4.1.1 Basic Level
  3. 4.1.2 Research Level
  4. 4.2 Global NK Cell Serum-Free Medium Sales by Type
  5. 4.2.1 Global NK Cell Serum-Free Medium Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global NK Cell Serum-Free Medium Sales by Type (2021-2032)
  7. 4.2.3 Global NK Cell Serum-Free Medium Sales Market Share by Type (2021-2032)
  8. 4.3 Global NK Cell Serum-Free Medium Revenue by Type
  9. 4.3.1 Global NK Cell Serum-Free Medium Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global NK Cell Serum-Free Medium Revenue by Type (2021-2032)
  11. 4.3.3 Global NK Cell Serum-Free Medium Revenue Market Share by Type (2021-2032)
5 NK Cell Serum-Free Medium Market by Application
  1. 5.1 NK Cell Serum-Free Medium Application Introduction
  2. 5.1.1 Biotechnology Company
  3. 5.1.2 Universities and Research Institutes
  4. 5.1.3 Hospital
  5. 5.2 Global NK Cell Serum-Free Medium Sales by Application
  6. 5.2.1 Global NK Cell Serum-Free Medium Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global NK Cell Serum-Free Medium Sales by Application (2021-2032)
  8. 5.2.3 Global NK Cell Serum-Free Medium Sales Market Share by Application (2021-2032)
  9. 5.3 Global NK Cell Serum-Free Medium Revenue by Application
  10. 5.3.1 Global NK Cell Serum-Free Medium Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global NK Cell Serum-Free Medium Revenue by Application (2021-2032)
  12. 5.3.3 Global NK Cell Serum-Free Medium Revenue Market Share by Application (2021-2032)
6 Global NK Cell Serum-Free Medium Sales by Region
  1. 6.1 Global NK Cell Serum-Free Medium Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global NK Cell Serum-Free Medium Sales by Region (2021-2032)
  3. 6.2.1 Global NK Cell Serum-Free Medium Sales by Region (2021-2026)
  4. 6.2.2 Global NK Cell Serum-Free Medium Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America NK Cell Serum-Free Medium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America NK Cell Serum-Free Medium Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe NK Cell Serum-Free Medium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe NK Cell Serum-Free Medium Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific NK Cell Serum-Free Medium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific NK Cell Serum-Free Medium Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa NK Cell Serum-Free Medium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa NK Cell Serum-Free Medium Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global NK Cell Serum-Free Medium Revenue by Region
  1. 7.1 Global NK Cell Serum-Free Medium Revenue by Region
  2. 7.1.1 Global NK Cell Serum-Free Medium Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global NK Cell Serum-Free Medium Revenue by Region (2021-2026)
  4. 7.1.3 Global NK Cell Serum-Free Medium Revenue by Region (2027-2032)
  5. 7.1.4 Global NK Cell Serum-Free Medium Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America NK Cell Serum-Free Medium Revenue (2021-2032)
  8. 7.2.2 North America NK Cell Serum-Free Medium Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe NK Cell Serum-Free Medium Revenue (2021-2032)
  11. 7.3.2 Europe NK Cell Serum-Free Medium Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific NK Cell Serum-Free Medium Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific NK Cell Serum-Free Medium Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa NK Cell Serum-Free Medium Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa NK Cell Serum-Free Medium Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Fujifilm
  2. 8.1.1 Fujifilm Company Information
  3. 8.1.2 Fujifilm Business Overview
  4. 8.1.3 Fujifilm NK Cell Serum-Free Medium Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Fujifilm NK Cell Serum-Free Medium Product Portfolio
  6. 8.1.5 Fujifilm Recent Developments
  7. 8.2 Thermo Fisher Scientific
  8. 8.2.1 Thermo Fisher Scientific Company Information
  9. 8.2.2 Thermo Fisher Scientific Business Overview
  10. 8.2.3 Thermo Fisher Scientific NK Cell Serum-Free Medium Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Thermo Fisher Scientific NK Cell Serum-Free Medium Product Portfolio
  12. 8.2.5 Thermo Fisher Scientific Recent Developments
  13. 8.3 BioLife Solutions
  14. 8.3.1 BioLife Solutions Company Information
  15. 8.3.2 BioLife Solutions Business Overview
  16. 8.3.3 BioLife Solutions NK Cell Serum-Free Medium Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 BioLife Solutions NK Cell Serum-Free Medium Product Portfolio
  18. 8.3.5 BioLife Solutions Recent Developments
  19. 8.4 Sartorius
  20. 8.4.1 Sartorius Company Information
  21. 8.4.2 Sartorius Business Overview
  22. 8.4.3 Sartorius NK Cell Serum-Free Medium Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sartorius NK Cell Serum-Free Medium Product Portfolio
  24. 8.4.5 Sartorius Recent Developments
  25. 8.5 Cytiva
  26. 8.5.1 Cytiva Company Information
  27. 8.5.2 Cytiva Business Overview
  28. 8.5.3 Cytiva NK Cell Serum-Free Medium Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Cytiva NK Cell Serum-Free Medium Product Portfolio
  30. 8.5.5 Cytiva Recent Developments
  31. 8.6 WAK-Chemie Medical
  32. 8.6.1 WAK-Chemie Medical Company Information
  33. 8.6.2 WAK-Chemie Medical Business Overview
  34. 8.6.3 WAK-Chemie Medical NK Cell Serum-Free Medium Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 WAK-Chemie Medical NK Cell Serum-Free Medium Product Portfolio
  36. 8.6.5 WAK-Chemie Medical Recent Developments
  37. 8.7 Zenoaq
  38. 8.7.1 Zenoaq Company Information
  39. 8.7.2 Zenoaq Business Overview
  40. 8.7.3 Zenoaq NK Cell Serum-Free Medium Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Zenoaq NK Cell Serum-Free Medium Product Portfolio
  42. 8.7.5 Zenoaq Recent Developments
  43. 8.8 Merck
  44. 8.8.1 Merck Company Information
  45. 8.8.2 Merck Business Overview
  46. 8.8.3 Merck NK Cell Serum-Free Medium Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Merck NK Cell Serum-Free Medium Product Portfolio
  48. 8.8.5 Merck Recent Developments
  49. 8.9 Vitrolife Group
  50. 8.9.1 Vitrolife Group Company Information
  51. 8.9.2 Vitrolife Group Business Overview
  52. 8.9.3 Vitrolife Group NK Cell Serum-Free Medium Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Vitrolife Group NK Cell Serum-Free Medium Product Portfolio
  54. 8.9.5 Vitrolife Group Recent Developments
  55. 8.10 Lifeline (ISCO)
  56. 8.10.1 Lifeline (ISCO) Company Information
  57. 8.10.2 Lifeline (ISCO) Business Overview
  58. 8.10.3 Lifeline (ISCO) NK Cell Serum-Free Medium Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Lifeline (ISCO) NK Cell Serum-Free Medium Product Portfolio
  60. 8.10.5 Lifeline (ISCO) Recent Developments
  61. 8.11 Capricorn
  62. 8.11.1 Capricorn Company Information
  63. 8.11.2 Capricorn Business Overview
  64. 8.11.3 Capricorn NK Cell Serum-Free Medium Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Capricorn NK Cell Serum-Free Medium Product Portfolio
  66. 8.11.5 Capricorn Recent Developments
  67. 8.12 BioLegend
  68. 8.12.1 BioLegend Company Information
  69. 8.12.2 BioLegend Business Overview
  70. 8.12.3 BioLegend NK Cell Serum-Free Medium Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 BioLegend NK Cell Serum-Free Medium Product Portfolio
  72. 8.12.5 BioLegend Recent Developments
  73. 8.13 Miltenyi Biotec
  74. 8.13.1 Miltenyi Biotec Company Information
  75. 8.13.2 Miltenyi Biotec Business Overview
  76. 8.13.3 Miltenyi Biotec NK Cell Serum-Free Medium Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Miltenyi Biotec NK Cell Serum-Free Medium Product Portfolio
  78. 8.13.5 Miltenyi Biotec Recent Developments
  79. 8.14 CooperSurgical
  80. 8.14.1 CooperSurgical Company Information
  81. 8.14.2 CooperSurgical Business Overview
  82. 8.14.3 CooperSurgical NK Cell Serum-Free Medium Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 CooperSurgical NK Cell Serum-Free Medium Product Portfolio
  84. 8.14.5 CooperSurgical Recent Developments
  85. 8.15 Yocon Biology
  86. 8.15.1 Yocon Biology Company Information
  87. 8.15.2 Yocon Biology Business Overview
  88. 8.15.3 Yocon Biology NK Cell Serum-Free Medium Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Yocon Biology NK Cell Serum-Free Medium Product Portfolio
  90. 8.15.5 Yocon Biology Recent Developments
  91. 8.16 Selcell
  92. 8.16.1 Selcell Company Information
  93. 8.16.2 Selcell Business Overview
  94. 8.16.3 Selcell NK Cell Serum-Free Medium Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Selcell NK Cell Serum-Free Medium Product Portfolio
  96. 8.16.5 Selcell Recent Developments
  97. 8.17 Shanghai Epizyme
  98. 8.17.1 Shanghai Epizyme Company Information
  99. 8.17.2 Shanghai Epizyme Business Overview
  100. 8.17.3 Shanghai Epizyme NK Cell Serum-Free Medium Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Shanghai Epizyme NK Cell Serum-Free Medium Product Portfolio
  102. 8.17.5 Shanghai Epizyme Recent Developments
  103. 8.18 ExCell Bio
  104. 8.18.1 ExCell Bio Company Information
  105. 8.18.2 ExCell Bio Business Overview
  106. 8.18.3 ExCell Bio NK Cell Serum-Free Medium Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 ExCell Bio NK Cell Serum-Free Medium Product Portfolio
  108. 8.18.5 ExCell Bio Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 NK Cell Serum-Free Medium Value Chain Analysis
  2. 9.1.1 NK Cell Serum-Free Medium Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 NK Cell Serum-Free Medium Production Mode & Process
  6. 9.2 NK Cell Serum-Free Medium Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 NK Cell Serum-Free Medium Distributors
  9. 9.2.3 NK Cell Serum-Free Medium Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst